JANE STREET GROUP, LLC - UROGEN PHARMA LTD ownership

UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 80 filers reported holding UROGEN PHARMA LTD in Q3 2020. The put-call ratio across all filers is 1.12 and the average weighting 0.2%.

Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of UROGEN PHARMA LTD
ValueSharesWeighting
Q3 2023$140,899
+1.9%
10,057
-24.7%
0.00%
Q2 2023$138,224
-82.4%
13,355
-84.3%
0.00%
Q1 2023$784,199
-43.3%
84,870
+18.3%
0.00%
Q3 2020$1,383,000
-26.9%
71,738
-0.9%
0.00%
Q2 2020$1,891,000
+632.9%
72,366
+400.1%
0.00%
Q1 2020$258,000
-75.6%
14,469
-54.4%
0.00%
-100.0%
Q4 2019$1,058,000
+366.1%
31,719
+595.1%
0.00%0.0%
Q2 2018$227,0004,5630.00%
Other shareholders
UROGEN PHARMA LTD shareholders Q3 2020
NameSharesValueWeighting ↓
Wildcat Capital Management, LLC 1,252,285$24,156,0007.72%
Horton Capital Management, LLC 375,428$7,242,0006.96%
MENORA MIVTACHIM HOLDINGS LTD. 2,954,699$56,996,0001.27%
Phoenix Holdings Ltd. 901,979$16,405,0000.69%
SHIKIAR ASSET MANAGEMENT INC 44,550$859,0000.33%
Coastal Bridge Advisors, LLC 37,000$714,0000.22%
Migdal Insurance & Financial Holdings Ltd. 738,302$14,242,0000.20%
Clal Insurance Enterprises Holdings Ltd 529,388$10,212,0000.17%
Vivaldi Capital Management LP 10,000$233,0000.05%
MEITAV INVESTMENT HOUSE LTD 48,407$934,0000.05%
View complete list of UROGEN PHARMA LTD shareholders